JP2006514051A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006514051A5 JP2006514051A5 JP2004565376A JP2004565376A JP2006514051A5 JP 2006514051 A5 JP2006514051 A5 JP 2006514051A5 JP 2004565376 A JP2004565376 A JP 2004565376A JP 2004565376 A JP2004565376 A JP 2004565376A JP 2006514051 A5 JP2006514051 A5 JP 2006514051A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- unsubstituted
- disubstituted
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000217 alkyl group Chemical group 0.000 claims 8
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 6
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 4
- 229940123769 Xanthine oxidase inhibitor Drugs 0.000 claims 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 4
- 125000005843 halogen group Chemical group 0.000 claims 4
- 239000003064 xanthine oxidase inhibitor Substances 0.000 claims 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 3
- 125000003277 amino group Chemical group 0.000 claims 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 229910019142 PO4 Inorganic materials 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000003282 alkyl amino group Chemical group 0.000 claims 2
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 2
- 125000005099 aryl alkyl carbonyl group Chemical group 0.000 claims 2
- 125000005129 aryl carbonyl group Chemical group 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 210000004165 myocardium Anatomy 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 2
- 239000010452 phosphate Substances 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 125000000027 (C1-C10) alkoxy group Chemical group 0.000 claims 1
- 125000003341 7 membered heterocyclic group Chemical group 0.000 claims 1
- 125000004442 acylamino group Chemical group 0.000 claims 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims 1
- 125000004104 aryloxy group Chemical group 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 230000000747 cardiac effect Effects 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical compound [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 0 *C1SC(CC2CC2)=*C(*)=C1 Chemical compound *C1SC(CC2CC2)=*C(*)=C1 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/325,420 US20040122067A1 (en) | 2002-12-20 | 2002-12-20 | Treatment of chronic heart failure |
| PCT/US2003/039410 WO2004060489A2 (en) | 2002-12-20 | 2003-12-11 | Treatment of chronic heart failure |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006514051A JP2006514051A (ja) | 2006-04-27 |
| JP2006514051A5 true JP2006514051A5 (https=) | 2007-02-01 |
Family
ID=32593758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004565376A Pending JP2006514051A (ja) | 2002-12-20 | 2003-12-11 | 慢性心不全の治療 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20040122067A1 (https=) |
| EP (1) | EP1581308A2 (https=) |
| JP (1) | JP2006514051A (https=) |
| CA (1) | CA2506719A1 (https=) |
| MX (1) | MXPA05006628A (https=) |
| PL (1) | PL375893A1 (https=) |
| WO (1) | WO2004060489A2 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005027887A2 (en) * | 2003-09-17 | 2005-03-31 | Cardimone Pharma Corporation | Methods and compositions for improving endothelial function |
| EP1883405A4 (en) * | 2005-05-09 | 2010-01-27 | Takeda Pharmaceuticals North A | METHODS OF TREATING NEPHROLITHIASIS |
| US20090124623A1 (en) * | 2006-11-13 | 2009-05-14 | Christopher Lademacher | Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors |
| KR20150024919A (ko) * | 2006-11-13 | 2015-03-09 | 다케다 파마슈티칼스 유에스에이, 인코포레이티드 | 크산틴 옥시도리덕타아제 억제제를 사용하여 신장 기능을 보존하는 방법 |
| AU2008206231A1 (en) * | 2007-01-19 | 2008-07-24 | Takeda Pharmaceuticals U.S.A., Inc. | Methods for preventing or reducing the number of gout flares using xanthine oxidoreductase inhibitors and anti-inflammatory agents |
| US20100311756A1 (en) * | 2009-01-22 | 2010-12-09 | Takeda Pharmaceuticals North America, Inc. | Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof |
| GB0909243D0 (en) * | 2009-05-29 | 2009-07-15 | Univ Dundee | Angina treatment |
| IT1400311B1 (it) | 2010-05-10 | 2013-05-24 | Menarini Int Operations Lu Sa | Associazione di inibitori della xantina ossidasi e antagonisti del recettore dell'angiotensina ii e loro uso. |
| IT1400310B1 (it) | 2010-05-10 | 2013-05-24 | Menarini Int Operations Lu Sa | Associazione di inibitori della xantina ossidasi e statine e loro uso. |
| IT1400609B1 (it) | 2010-05-10 | 2013-06-14 | Menarini Int Operations Lu Sa | Associazione di inibitori della xantina ossidasi e metformina e loro uso. |
| IT1400309B1 (it) | 2010-05-10 | 2013-05-24 | Menarini Int Operations Lu Sa | Associazione di inibitori della xantina ossidasi e calcio antagonisti e loro uso. |
| CA2812034C (en) | 2010-09-10 | 2018-10-23 | Takeda Pharmaceuticals U.S.A., Inc. | Methods for concomitant treatment of theophylline and febuxostat |
| WO2016017826A1 (ja) * | 2014-07-30 | 2016-02-04 | 帝人ファーマ株式会社 | キサンチンオキシダーゼ阻害薬 |
| WO2016133069A1 (ja) * | 2015-02-17 | 2016-08-25 | 株式会社 三和化学研究所 | 心不全の予防又は治療のための医薬 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0513379T3 (da) * | 1990-11-30 | 1996-09-30 | Teijin Ltd | 2-Arylthiazolderivater og farmaceutisk præparat indeholdende sådanne |
| US6191136B1 (en) * | 1997-11-07 | 2001-02-20 | Johns Hopkins University | Methods for treatment of disorders of cardiac contractility |
| ATE246197T1 (de) * | 1998-09-09 | 2003-08-15 | Metabasis Therapeutics Inc | Neue heteroaromatische fructose 1,6- bisphosphatase inhibitoren |
| ATE457169T1 (de) * | 1998-10-15 | 2010-02-15 | Imp Innovations Ltd | Verbindungen für die behandlung von gewichtsverlust |
| ATE365043T1 (de) * | 1999-03-09 | 2007-07-15 | Anker Stefan | Endotoxinhemmern zur behandlung von kachexie |
-
2002
- 2002-12-20 US US10/325,420 patent/US20040122067A1/en not_active Abandoned
-
2003
- 2003-12-11 PL PL03375893A patent/PL375893A1/xx unknown
- 2003-12-11 CA CA002506719A patent/CA2506719A1/en not_active Abandoned
- 2003-12-11 WO PCT/US2003/039410 patent/WO2004060489A2/en not_active Ceased
- 2003-12-11 EP EP03796950A patent/EP1581308A2/en not_active Withdrawn
- 2003-12-11 MX MXPA05006628A patent/MXPA05006628A/es unknown
- 2003-12-11 JP JP2004565376A patent/JP2006514051A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006514051A5 (https=) | ||
| RU2481346C2 (ru) | Ингибиторы фосфатидилинозитол-3-киназы | |
| JP2018507197A5 (https=) | ||
| JP2020505396A5 (https=) | ||
| JP2019512478A5 (https=) | ||
| RU2006112593A (ru) | Производные 2, 4-ди(гетеро)ариламинопиримидина в качестве ингибиторов zap-70 и/или syk | |
| RU2006134003A (ru) | Серосодержащие соединения, действующие как ингибиторы сериновой протеазы ns3 вируса гепатита с | |
| RU2003132687A (ru) | Лечение диабета типа 2 ингибиторами дипептидилпептидазы iv | |
| JP2008533191A5 (https=) | ||
| JP2006143737A5 (https=) | ||
| HUP0100950A2 (hu) | Ciklusos aminovegyületek, alkalmazásuk gyógyászati készítmények előállítására és a vegyületeket tartalmazó gyógyászati készítmények | |
| RU2003116123A (ru) | Амидоэфирзамещенные имидазохинолины | |
| JP2014500295A5 (https=) | ||
| JP2005539088A5 (https=) | ||
| RU2005114021A (ru) | Производные имидазола и их применение в качестве периферически-селективных ингибиторов дофамин-бета-гидролазы | |
| JP2008505157A5 (https=) | ||
| EA200500096A1 (ru) | Гетеробиарильные производные в качестве ингибиторов матриксных металлопротеиназ | |
| CA2539349A1 (en) | 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones | |
| CA2458025A1 (en) | Novel 4-aminofuropyrimidines and the use thereof | |
| JP2012513390A5 (https=) | ||
| RU2007130144A (ru) | Гетероциклические соединения в качестве антагонистов cccr2b | |
| JP2005526794A5 (ja) | ベンズイミダゾールおよびマイトジェン活性化およびｒｈｏキナーゼ阻害剤としてのその使用 | |
| JP2005517677A5 (https=) | ||
| RU2008119465A (ru) | Производные циклопропилуксусной кислоты и их применение | |
| JP2005527521A5 (https=) |